Biotech M&A Anomalies With Allan Shaw
Business Of Biotech · 50 minutes ·

Biotech M&A Anomalies With Allan Shaw

While many clinical-stage biopharmas are contracting or holding the line through the current market slump, Portage Biotech leaders Ian Walters, Allan Shaw, and company are making moves. The company recently acquired  Tarus Therapeutics and iOx Therapeutics Ltd., extending its pipeline and positioning itself to meet some aggressive investor expectations. On this episode of the Business of Biotech, Shaw dissects the deals, digging into the M&A strategy at Portage and offering advice from the batter's box to leaders of early-stage biotechs.

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

Breaking Biotech

Digital Biotech

Monsteropolis: Legends Anomalies Monsters

M&A Views

M&A Masters

M&A Unplugged

M&A Science

Dinner & Dialogue with Seane Shaw